Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Forbes

Showing results (171-180 of 313) with videos related to

Pageof 32
Sort By:
The American Journal of Medicine|December 1, 1991
Iloprost and risk of thromboembolismJ J Belch, C S Lau, A Saniabadi, et al.
British Medical Journal|May 10, 1980
Improving prospects for employment of the haemophiliacJ Stuart, C D Forbes, P Jones, et al.
Scottish Medical Journal|August 1, 1988
Does non-acetylated salicylate inhibit thromboxane biosynthesis in human platelets?B J Danesh, M McLaren, R I Russell, et al.
Thrombosis and Haemostasis|June 28, 1983
Blood viscosity and haemostasis in the nephrotic syndromeE McGinley, G D Lowe, M Boulton-Jones, et al.
Thrombosis Research|October 1, 1977
Effect of sulphinpyrazone and aspirin on latelet adhesion to activated charcoal and dialysis membranes in vitroJ F Winchester, C D Forbes, J M Courtney, et al.
British Medical Journal|October 19, 1974
Low-dosage ancrod for prevention of thrombotic complications after surgery for fractured neck of femurW W Barrie, E H Wood, P Crumlish, et al.
Lancet (London, England)|May 3, 1975
Raised amniotic-fluid F.D.P. in fetal neural-tube anomaliesD W Purdie, P W Howie, W Edgar, et al.
Haemostasis|January 1, 1989
Comparison of the effect of aspirin and choline magnesium trisalicylate on thromboxane biosynthesis in human platelets: role of the acetyl moietyB J Danesh, M McLaren, R I Russell, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1988
Microvascular disease and limited joint mobility in diabetes. A comparison of fibrinolysis and prostacyclin in diabetes and systemic sclerosisJ G Larkin, J J Belch, P Flanigan, et al.
Haemostasis|January 1, 1986
Effect of insulin therapy on coagulation and platelet function in type II (non-insulin-dependent) diabetes mellitusM Small, J T Douglas, G D Lowe, et al.
Pageof 32

Showing results (171-180 of 313) with videos related to

Sort By:
Pageof 32
The American Journal of Medicine|December 1, 1991
Iloprost and risk of thromboembolismJ J Belch, C S Lau, A Saniabadi, et al.
British Medical Journal|May 10, 1980
Improving prospects for employment of the haemophiliacJ Stuart, C D Forbes, P Jones, et al.
Scottish Medical Journal|August 1, 1988
Does non-acetylated salicylate inhibit thromboxane biosynthesis in human platelets?B J Danesh, M McLaren, R I Russell, et al.
Thrombosis and Haemostasis|June 28, 1983
Blood viscosity and haemostasis in the nephrotic syndromeE McGinley, G D Lowe, M Boulton-Jones, et al.
Thrombosis Research|October 1, 1977
Effect of sulphinpyrazone and aspirin on latelet adhesion to activated charcoal and dialysis membranes in vitroJ F Winchester, C D Forbes, J M Courtney, et al.
British Medical Journal|October 19, 1974
Low-dosage ancrod for prevention of thrombotic complications after surgery for fractured neck of femurW W Barrie, E H Wood, P Crumlish, et al.
Lancet (London, England)|May 3, 1975
Raised amniotic-fluid F.D.P. in fetal neural-tube anomaliesD W Purdie, P W Howie, W Edgar, et al.
Haemostasis|January 1, 1989
Comparison of the effect of aspirin and choline magnesium trisalicylate on thromboxane biosynthesis in human platelets: role of the acetyl moietyB J Danesh, M McLaren, R I Russell, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1988
Microvascular disease and limited joint mobility in diabetes. A comparison of fibrinolysis and prostacyclin in diabetes and systemic sclerosisJ G Larkin, J J Belch, P Flanigan, et al.
Haemostasis|January 1, 1986
Effect of insulin therapy on coagulation and platelet function in type II (non-insulin-dependent) diabetes mellitusM Small, J T Douglas, G D Lowe, et al.
Pageof 32